| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3192281 | Annals of Allergy, Asthma & Immunology | 2012 | 6 Pages |
Abstract
Overweight patients with persistent asthma may have attenuated symptom and FeNO dose responses to inhaled budesonide compared with normal weight patients with asthma, with no differences in FEV1 or methacholine PC20 between groups. Attenuated cortisol suppression in the overweight group may be the clue to this difference, alluding to reduced peripheral lung deposition or absorption in overweight patients with asthma.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
William J. MBChB, Brian J. MD,